Volume 32, Issue 23
Research Article

Simulating biologically plausible complex survival data

Michael J. Crowther

Corresponding Author

University of Leicester, Department of Health Sciences, Adrian Building, University Road, Leicester LE1 7RH, U.K.

Correspondence to: Michael J. Crowther, Department of Health Sciences, University of Leicester, Adrian Building, University Road, Leicester LE1 7RH, U.K.

E‐mail: michael.crowther@le.ac.uk

Search for more papers by this author
Paul C. Lambert

University of Leicester, Department of Health Sciences, Adrian Building, University Road, Leicester LE1 7RH, U.K.

Karolinksa Institutet, Department of Medical Epidemiology and Biostatistics, PO Box 281 S‐171 77, Stockholm, Sweden

Search for more papers by this author
First published: 23 April 2013
Citations: 49

Abstract

Simulation studies are conducted to assess the performance of current and novel statistical models in pre‐defined scenarios. It is often desirable that chosen simulation scenarios accurately reflect a biologically plausible underlying distribution. This is particularly important in the framework of survival analysis, where simulated distributions are chosen for both the event time and the censoring time. This paper develops methods for using complex distributions when generating survival times to assess methods in practice. We describe a general algorithm involving numerical integration and root‐finding techniques to generate survival times from a variety of complex parametric distributions, incorporating any combination of time‐dependent effects, time‐varying covariates, delayed entry, random effects and covariates measured with error. User‐friendly Stata software is provided. Copyright © 2013 John Wiley & Sons, Ltd.

Number of times cited according to CrossRef: 49

  • A Bayesian inference for the penalized spline joint models of longitudinal and time-to-event data: A prior sensitivity analysis, Monte Carlo Methods and Applications, 10.1515/mcma-2020-2058, 26, 1, (49-68), (2020).
  • Generalized parametric cure models for relative survival, Biometrical Journal, 10.1002/bimj.201900056, 62, 4, (989-1011), (2020).
  • Generating Survival Times Using Cox Proportional Hazards Models with Cyclic and Piecewise Time-Varying Covariates, Statistics in Biosciences, 10.1007/s12561-020-09266-3, (2020).
  • Comparison of propensity score methods for pre-specified subgroup analysis with survival data, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2020.1730868, (1-18), (2020).
  • Generalized Link-Based Additive Survival Models with Informative Censoring, Journal of Computational and Graphical Statistics, 10.1080/10618600.2020.1724544, (1-10), (2020).
  • Performance of methods to conduct mediation analysis with time‐to‐event outcomes, Statistica Neerlandica, 10.1111/stan.12191, 74, 1, (72-91), (2019).
  • Comparison of model-building strategies for excess hazard regression models in the context of cancer epidemiology, BMC Medical Research Methodology, 10.1186/s12874-019-0830-9, 19, 1, (2019).
  • Impact of model misspecification in shared frailty survival models, Statistics in Medicine, 10.1002/sim.8309, 38, 23, (4477-4502), (2019).
  • Joint modeling of progression‐free and overall survival and computation of correlation measures, Statistics in Medicine, 10.1002/sim.8295, 38, 22, (4270-4289), (2019).
  • Bootstrapping complex time‐to‐event data without individual patient data, with a view toward time‐dependent exposures, Statistics in Medicine, 10.1002/sim.8177, 38, 20, (3747-3763), (2019).
  • Using simulation studies to evaluate statistical methods, Statistics in Medicine, 10.1002/sim.8086, 38, 11, (2074-2102), (2019).
  • How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies, BMC Medical Research Methodology, 10.1186/s12874-019-0808-7, 19, 1, (2019).
  • Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring, BMC Medical Research Methodology, 10.1186/s12874-019-0709-9, 19, 1, (2019).
  • Are non-constant rates and non-proportional treatment effects accounted for in the design and analysis of randomised controlled trials? A review of current practice, BMC Medical Research Methodology, 10.1186/s12874-019-0749-1, 19, 1, (2019).
  • Evaluating antimalarial efficacy in single-armed and comparative drug trials using competing risk survival analysis: a simulation study, BMC Medical Research Methodology, 10.1186/s12874-019-0748-2, 19, 1, (2019).
  • Multilevel mixed-effects parametric survival analysis: Estimation, simulation, and application, The Stata Journal: Promoting communications on statistics and Stata, 10.1177/1536867X19893639, 19, 4, (931-949), (2019).
  • Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study, Communications in Statistics - Simulation and Computation, 10.1080/03610918.2019.1634201, (1-17), (2019).
  • Generating survival times with time-varying covariates using the Lambert W Function, Communications in Statistics - Simulation and Computation, 10.1080/03610918.2019.1648822, (1-19), (2019).
  • Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times?, Statistical Methods in Medical Research, 10.1177/0962280218780856, 28, 8, (2475-2493), (2018).
  • Flexible and structured survival model for a simultaneous estimation of non-linear and non-proportional effects and complex interactions between continuous variables: Performance of this multidimensional penalized spline approach in net survival trend analysis, Statistical Methods in Medical Research, 10.1177/0962280218779408, 28, 8, (2368-2384), (2018).
  • A modified two-stage approach for joint modelling of longitudinal and time-to-event data, Journal of Statistical Computation and Simulation, 10.1080/00949655.2018.1518449, 88, 17, (3379-3398), (2018).
  • Nonlinear association structures in flexible Bayesian additive joint models, Statistics in Medicine, 10.1002/sim.7967, 37, 30, (4771-4788), (2018).
  • Explained variation of excess hazard models, Statistics in Medicine, 10.1002/sim.7645, 37, 14, (2284-2300), (2018).
  • Simulation-based power calculations for planning a two-stage individual participant data meta-analysis, BMC Medical Research Methodology, 10.1186/s12874-018-0492-z, 18, 1, (2018).
  • Penalized Spline Joint Models for Longitudinal and Time-To-Event Data, Topics in Splines and Applications, 10.5772/intechopen.68737, (2018).
  • Strcs: A Command for Fitting Flexible Parametric Survival Models on the Log-hazard Scale, The Stata Journal: Promoting communications on statistics and Stata, 10.1177/1536867X1601600410, 16, 4, (989-1012), (2018).
  • Simulating Duration Data for the Cox Model, Political Science Research and Methods, 10.1017/psrm.2018.19, (1-8), (2018).
  • Statistical power to detect violation of the proportional hazards assumption when using the Cox regression model, Journal of Statistical Computation and Simulation, 10.1080/00949655.2017.1397151, 88, 3, (533-552), (2017).
  • A comparison of the conditional inference survival forest model to random survival forests based on a simulation study as well as on two applications with time-to-event data, BMC Medical Research Methodology, 10.1186/s12874-017-0383-8, 17, 1, (2017).
  • Parametric multistate survival models: Flexible modelling allowing transition‐specific distributions with application to estimating clinically useful measures of effect differences, Statistics in Medicine, 10.1002/sim.7448, 36, 29, (4719-4742), (2017).
  • Flexible Bayesian additive joint models with an application to type 1 diabetes research, Biometrical Journal, 10.1002/bimj.201600224, 59, 6, (1144-1165), (2017).
  • Guidelines for generating right-censored outcomes from a Cox model extended to accommodate time-varying covariates, Journal of Modern Applied Statistical Methods, 10.22237/jmasm/1493597100, 16, 1, (86-106), (2017).
  • Parametric and penalized generalized survival models, Statistical Methods in Medical Research, 10.1177/0962280216664760, 27, 5, (1531-1546), (2016).
  • Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study, Statistical Methods in Medical Research, 10.1177/0962280216642264, 27, 3, (765-784), (2016).
  • One‐stage individual participant data meta‐analysis models: estimation of treatment‐covariate interactions must avoid ecological bias by separating out within‐trial and across‐trial information, Statistics in Medicine, 10.1002/sim.7171, 36, 5, (772-789), (2016).
  • Simulating survival data with predefined censoring rates for proportional hazards models, Statistics in Medicine, 10.1002/sim.7178, 36, 5, (838-854), (2016).
  • Penalized spline joint models for longitudinal and time-to-event data, Communications in Statistics - Theory and Methods, 10.1080/03610926.2016.1235195, 46, 20, (10294-10314), (2016).
  • Flexible parametric modelling of the cause‐specific cumulative incidence function, Statistics in Medicine, 10.1002/sim.7208, 36, 9, (1429-1446), (2016).
  • Temporal aspects of air pollutant measures in epidemiologic analysis: a simulation study, Scientific Reports, 10.1038/srep19691, 6, 1, (2016).
  • Joint modelling of longitudinal and multi‐state processes: application to clinical progressions in prostate cancer, Statistics in Medicine, 10.1002/sim.6972, 35, 22, (3933-3948), (2016).
  • It’s About Time, Epidemiology, 10.1097/EDE.0000000000000413, (1), (2015).
  • Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification, Statistics in Medicine, 10.1002/sim.6779, 35, 7, (1193-1209), (2015).
  • Womenʼs Health Initiative estrogen plus progestin clinical trial, Menopause, 10.1097/GME.0000000000000472, 22, 12, (1317-1322), (2015).
  • Comparison of different approaches to estimating age standardized net survival, BMC Medical Research Methodology, 10.1186/s12874-015-0057-3, 15, 1, (2015).
  • Bias and precision of measures of survival gain from right‐censored data, Pharmaceutical Statistics, 10.1002/pst.1700, 14, 5, (409-417), (2015).
  • Statistical Inference Methods for Two Crossing Survival Curves: A Comparison of Methods, PLOS ONE, 10.1371/journal.pone.0116774, 10, 1, (e0116774), (2015).
  • Adjusting for treatment switching in randomised controlled trials – A simulation study and a simplified two-stage method, Statistical Methods in Medical Research, 10.1177/0962280214557578, 26, 2, (724-751), (2014).
  • A general framework for parametric survival analysis, Statistics in Medicine, 10.1002/sim.6300, 33, 30, (5280-5297), (2014).
  • Bayesian regularization for flexible baseline hazard functions in Cox survival models, Biometrical Journal, 10.1002/bimj.201900211, 0, 0, (undefined).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.